Back to the main directory
Press Release
- Gain Therapeutics to Present at Michael J. Fox Foundation’s 16th Annual Parkinson’s Disease Therapeutics Conference by GlobeNewsWire
- Form 8.3 - Balanced Commercial Property Trust Limited by GlobeNewsWire
- Form 8.3 - Keywords Studios Plc by GlobeNewsWire
- Sonnet BioTherapeutics Inc. Enters into Licensing Agreement with Alkem Laboratories Limited to Develop and Commercialize SON-080 for Diabetic Peripheral Neuropathy (DPN) in India by GlobeNewsWire
- WTW launches partnership with the University of Colorado Boulder to harness the climate prediction revolution by GlobeNewsWire
- Kronos Bio to Present Data at the EORTC-NCI-AACR Symposium that Supports p300 KAT Inhibition in HPV-Driven Tumors by GlobeNewsWire
- 1-800-FLOWERS.COM, Inc. to Release its Fiscal 2025 First Quarter Results on Thursday, October 31, 2024 by BusinessWire
- Decision of the Management Board of Šiaulių Bankas AB on acquisition of own shares by GlobeNewsWire
- AIM ImmunoTech to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC by GlobeNewsWire
- Sportsman’s Warehouse Announces Ryan Carroll as VP Performance Marketing by GlobeNewsWire
- ibex Partners with Parloa for Latest GenAI Capabilities by GlobeNewsWire
- NUCDF and Zevra Therapeutics Launch Check Ammonia Campaign to Highlight Critical Importance of Prompt, Accurate Blood Ammonia Testing for Diagnosing Urea Cycle Disorders by GlobeNewsWire
- Form 8.3 - The Vanguard Group, Inc.: Spirent Communications plc by EQS Group AG
- IDEX Biometrics ASA’s extraordinary general meeting held on 9 October 2024 by GlobeNewsWire
- Form 8.3 - The Vanguard Group, Inc.: Ascential plc by EQS Group AG
- Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc by EQS Group AG
- Form 8.3 - The Vanguard Group, Inc.: International Distribution Services plc by EQS Group AG
- GE HealthCare Accelerates Artificial Intelligence Adoption With New Offering to Advance Enterprise Imaging by BusinessWire
- Net Asset Value(s) by GlobeNewsWire
- Form 8.3 - The Vanguard Group, Inc.: International Paper Company by EQS Group AG
- Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc by EQS Group AG
- Form 8.3 - The Vanguard Group, Inc.: Centamin plc by EQS Group AG
- Capricor Therapeutics Announces Initiation of Rolling Submission of Biologics License Application (BLA) with U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy by GlobeNewsWire
- Inhibikase Therapeutics Announces Pricing of $110 Million Private Placement to Advance IkT-001Pro, an Optimized Prodrug of Imatinib, into a Late-Stage Trial in Pulmonary Arterial Hypertension by GlobeNewsWire
- StepStone Private Wealth Surpasses $5 Billion in AUM Milestone by GlobeNewsWire